drugset / Trial / NCT05763043

Monoferric for Prenatal Iron Deficiency

NCT05763043

Phase 0 Recruiting 80 enrolled Oregon Health and Science University
NaSingle-groupOpen-labelTreatment

Summary

A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.

Timeline

Start
2024-01-18
Primary completion
2028-10
Completion
2028-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric Derisomaltose Unknown 1000 mg Intravenous

Indications